The accumulation of those glycated proteins into heavily crosslinked AGEs have been shown in Bruch’s membrane and drusen from ageing eyes and at increased levels in patients with AMD [5,6,36,37,38,39], which were significantly decreased after treatment with FN3K. The gene discussed is FN3K; the disease is age-related macular degeneration.